Concepedia

Chris Torrance

CT

Statistics

Publications

6

Citations

1.3K

H-Index

6

Active since

1999

Affiliations

Horizon Discovery (United Kingdom)(Current)

Howard Hughes Medical Institute

Chris Torrance is an author at Horizon Discovery (United Kingdom) specializing in oncology, molecular oncology, and medicine.

Publications per year

1999–2016

6

Publications

6

Disruption of p53 in human cancer cells alters the responses to therapeutic agents

Fred Bunz, Paul M. Hwang, Chris Torrance et al. · Journal of Clinical Investigation · 1999 · 1.1K citations · Full text

, , +17

Synthetic Lethal Targeting of <i>ARID1A</i> -Mutant Ovarian Clear Cell Tumors with Dasatinib

Rowan Miller, Rachel Brough, Ilirjana Bajrami et al. · Molecular Cancer Therapeutics · 2016 · 85 citations · Full text

, , +17

TP53-independent Function of miR-34a via HDAC1 and p21CIP1/WAF1

Jane Zhao, Paul Lammers, Chris Torrance et al. · Molecular Therapy · 2013 · 59 citations · Full text

, , +17

Predictive biomarker discovery through the parallel integration of clinical trial and functional genomics datasets

Charles Swanton, James Larkin, Marco Gerlinger et al. · Genome Medicine · 2010 · 43 citations · Full text

, , +17

Circulating pEGFR Is a Candidate Response Biomarker of Cetuximab Therapy in Colorectal Cancer

Mercè Juliachs, Josep Gregori, Teresa Macarulla et al. · Clinical Cancer Research · 2014 · 25 citations · Full text

, , +17

1–5 of 6